Welcome to AdvanceTech Monitor

Featured products

See details Autoimmune Market Outlook to 2012 Autoimmune Market Outlook to 2012 is a new report published by Business Insights, examining how the competitive dynamics of major pharma companies will influence the market positions of products and shape the direction of future global autoimmunology. Market trends and leading brands of treatment are extensively profiled, while the most commercially promising R&D therapies are investigated and assessed to discover their sales potential. Our price: $ 2,875.00 See details Winning Product Launch Strategies: Maximizing sales from new pharmaceutical products 2011 With pharmaceutical R&D continuing to suffer from declining productivity levels and stagnant returns on investment, effective, flexible and commercially successful new product launches have become more important than ever. How pharma companies drive product uptake and the effectiveness of their competitive positioning during the launch phase increasingly define pharmaceutical market success. Winning Product Launch Strategies is a new report featuring case studies of successful product launches of several key drugs. The results of 163 new product approvals and launches conducted across the US and EU are analyzed to provide up-to-date information on trends in new drug launches along with key factors for successful launches. Our price: $ 2,875.00 See details Pharmaceutical Thought Leaders 2007: Determining Fair-Market Value and Measuring ROI Thought leader development is coming under increased scrutiny from regulatory bodies to eliminate the “potential for fraud and abuse” between the pharmaceutical industry and the medical community. Pharmaceutical companies have enacted compliance policies that allow fair-market compensation for thought leaders in exchange for their consultant and advisory services. The pharmaceutical industry spends millions of dollars each year in payments to KOLs. With so much money at stake, pharma companies need to protect themselves from unnecessary regulatory scrutiny and avoid compliance fines. Although fair-market value payments reduces companies’ liability and removes conflict of interest issues, thought leader managers still struggle to define what fair-market value is. This report provides a solution for segmenting thought leader candidates and defining fair-market value compensation. Our price: $ 7,695.00